Karyopharm Therapeutics

KPTINasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$41.280 M

$1.82 -2.15%

Close of 22 Sept 2026

Revenue

$146.1M

#2396 by revenue

Earnings

-$196.0M

Loss-making

Shares outstanding

22,681,460

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#362ImmutepIMMP$41.7M
#363Lite StrategyLITS$41.4M
#364Karyopharm TherapeuticsKPTI$41.3M
#365Incannex HealthcareIXHL$40.6M
#366Seres TherapeuticsMCRB$40.4M

What if Karyopharm Therapeutics were worth as much as…

Open the what-if tool →

Gold $30.2T

$1,332,982

Per share 732,407× higher

Bitcoin $1.74T

$76,787.61

Per share 42,191× higher

Nvidia $5.52T

$243,183.95

Per share 133,618× higher

Or at a round number

$50.0M $100.0M $200.0M $500.0M

Where these numbers come from

Share counts and financials for Karyopharm Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.